UH
UTHR icon

Unigestion Holding’s United Therapeutics UTHR Stock Holding History

Unigestion Holding’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$2.67M Buy
+8,668
New +$2.97M 0.16% 101
2021
Q3 		– Sell
-4,773
Closed -$845K – 235
2021
Q2 		$845K Buy
4,773
+1,122
+31% +$214K 0.03% 180
2021
Q1 		$611K Buy
+3,651
New +$609K 0.02% 192
2019
Q3 		– Sell
-9,879
Closed -$771K – 267
2019
Q2 		$771K Buy
+9,879
New +$924K 0.02% 200

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Unigestion Holding's UTHR Position: Q1 2025 in Review

Unigestion Holding opened a new position in United Therapeutics (UTHR) in Q1 2025: 8,668 shares worth $2.67M. The stake represents 0.16% of the portfolio and ranks #101 among its holdings. This is a return to the name: Unigestion Holding previously reported a position in UTHR as recently as Q2 2021.

Unigestion Holding first reported a position in UTHR in Q2 2019 and has held it in 4 quarters since. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Unigestion Holding held 8,668 shares of United Therapeutics worth $2.67M as of Q1 2025.
  • United Therapeutics was a new Unigestion Holding position in Q1 2025.
  • United Therapeutics made up 0.16% of Unigestion Holding's portfolio in Q1 2025, its #101 holding.
  • Unigestion Holding first reported a position in United Therapeutics in Q2 2019 and has held it in 4 quarters since.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Unigestion Holding's 13F filing for Q1 2025, filed 10 Apr 2025.